High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance

Tropical Medicine and International Health

Volumn 2, Issue 11, 1997, Pages 1075-1079

  Jelinek, Tomas ^a   Ronn A M ^a   Curtis, J ^a   Duraisingh, M T ^b   Lemnge, M M ^a   Mhina, J ^c   Bygbjerg, I C ^b   Warhurst, D C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b University of Copenhagen   (Denmark)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

Plasmodium falciparum; Sulfadoxine pyrimethamine resistance; Tanzania

Indexed keywords

DIHYDROFOLATE REDUCTASE; PYRIMETHAMINE; SULFADOXINE;

ARTICLE; DRUG METABOLISM; GENE MUTATION; HUMAN; INFECTION RISK; MALARIA; PLASMODIUM FALCIPARUM; TANZANIA;

PLASMODIUM FALCIPARUM;

EID: 0030678031     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1997.d01-189.x     Document Type: Article

References (18)

1. Anonymous (1991) Basic Malaria Microscopy. World Health Organization, Geneva.
2. Basco L, de Pecoulas P, Wilson C, Le Bras J & Mazabraud A (1995) Point mutations in the dihydrofolate reductase- thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Molecular Biochemistry and Parasitology 69, 135-138.
3. Chulay J, Watkins W & Sixsmith D (1984) Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vivo. American Journal of Tropical Medicine and Hygiene 33, 325-330.
4. Clyde D & Shute G (1957) Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Transactions of the Royal Society of Tropical Medicine and Hygiene 51, 505-513.
5. Clyde D (1954) Observations on monthly pyrimethamine ('Daraprim') prophylaxis in an East African village. East African Medical Journal 3, 41-46.
6. Cowman A, Worry M, Biggs B, Cross G, & Foote S (1988) Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proceedings of the National Academy of Science of the United States of America 85, 9109-9113.
7. Curtis J, Duraisingh M, Trigg J, Mbwana H, Warhurst D & Curtis C (1996) Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 678-680.
8. Foote S, Galatis D & Cowman A (1990) Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Science of the United States of America 87, 3014-3017.
9. Peterson D, Walliker D & Wellems T (1988) Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Science of the United States of America 85, 9114-9118.
10. Peterson D, Milhous W & Wellems T (1990) Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Science of the United States of America 87, 3018-3021.
11. Plowe CV, Djimde A, Bouare M, Doumbo O & Wellems TE (1995) Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene 52, 565-568.
12. Reeder J, Rieckmann K, Genton B, Lorry K, Wines B & Cowman A (1996) Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. American Journal of Tropical Medicine and Hygiene 55, 209-213.
13. Rønn A, Msangeni H, Mhina J, Wernsdorfer W & Bybjerg I (1996) High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 179-181.
14. Snewin V, England S, Sims P & Hyde J (1989) Characterization of the dihydrofolate reductase-thymidylate symhase gene from human malaria parasites highly resistant to pyrimethamine. Gene 76, 41-52.
15. Thaithong S, Chang S, Songsomboon S, Wilairat P, Seesod N, Sueblinwong T et al. (1992) Pyrimethamine resistant mutations in Plasmodium falciparum. Molecular Biochemistry and Parasitology 52, 149-158.
16. Timmermanns P, Hess U & Jones M (1982) Pyrimethamine/sulfadoxme resistant falciparum malaria in East Africa. Lancet i, 1181.
17. Vleugels M, Wetsteyn J & Meuwissen J (1981) Fansidar- resistant Plasmodium falciparum infection from Tanzania. Tropical Geographical Medicine 34, 263-265.
18. Zolg W, Plitt J, Chen G & Palmer S (1989) Point mutations in the dihydrofolate reductase-thymidylate symhase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Molecular Biochemistry and Parasitology 36, 253-262.